Skip to main content
Caplight Logo









Celeos SAS

Celeos SAS

Private
LilleHealthcare & Life Scienceshttps://celeos.ai

Last Round

Seed

Jul 24, 2025

Total Funding Raised

$1.72M

Company Overview

Celeos SAS operates in Healthcare & Life Sciences and is based in Lille. Its latest recorded funding round was a Seed round in July 2025.

Celeos SAS is a medical technology company that develops SpiderMass, an innovative diagnostic device using laser-based molecular imaging and machine learning to assist oncological surgeons in real-time tissue analysis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Celeos SAS Comparables

Compare Celeos SAS with similar companies based on industry and business-model similarity.

Celeos SAS comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Marginum
86%
Reveal Surgical
83%
MS Pen Technologies, Inc.
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Celeos SAS Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 24, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Philippe Saudemont

Chief Executive Officer

Executive Team

Marc Kowalczyk, BMEng, MBA

Chief Technology Officer

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2025

    $1.72M raised in Seed round.

  • Jan 14, 2025

    Grew 75% QoQ, from 4 to 7 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Celeos SAS Filings

Explore SEC and related filing metadata, where available.

Celeos SAS filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Celeos SAS's valuation, stock price, and market status.

Is Celeos SAS a public or private company?

Celeos SAS is a private company.

What is the current stock price of Celeos SAS?

Celeos SAS is a private company, so its shares have no public market price. Caplight tracks Celeos SAS's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Celeos SAS worth (valuation)?

Valuation information for Celeos SAS is not publicly available.

Can I buy Celeos SAS stock?

Celeos SAS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Celeos SAS's last funding round?

Celeos SAS's most recent funding round was Seed on July 24, 2025.

Who are the main investors in Celeos SAS?

Investor information for Celeos SAS is not publicly disclosed.

Will Celeos SAS IPO soon?

No public IPO plans have been announced for Celeos SAS.

How can I track Celeos SAS secondary market activity?

Caplight tracks bids, offers, and trades in Celeos SAS's shares on secondary markets.

Firmographic Details

HeadquartersLille
Employee Range9
Year Founded2023
Last FundingJul 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?